Spatial Genomics - About the company
Spatial Genomics is a series A company based in Pasadena (United States), founded in 2018 by Drew Kennedy. It operates as a Developer of multiplexed assays for drug development. Spatial Genomics has raised $56M in funding from Fulgent Genetics. The company has 7 active competitors, including 4 funded and 1 that has exited. Its top competitors include companies like Cellectricon, Intana Bioscience and BioAssay Systems.
Company Details
Developer of multiplexed assays for drug development. The company develops sequential fluorescence in situ hybridization (seqFISH) an advanced biomolecular analysis method with combinatorial molecular barcoding for fundamental biology, precision medicine, drug development, and diagnostics.http://spatialgenomics.com/
- Website
- spatialgenomics.com
- Email ID
- *****@spatialgenomics.com
- Phone Number
- +1 **********
- Registered Address
- 145 Vista Ave Suite 111 Pasadena, CA 91107
Key Metrics
Founded Year
2018
Location
Pasadena, United States
Stage
Series A
Total Funding
$56M in 8 rounds
Latest Funding Round
Investors
Ranked
1st among 7 active competitors
Employee Count
12 as on Aug 31, 2026
Similar Companies
Legal entities associated with Spatial Genomics
Spatial Genomics is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
SPATIAL GENOMICS, INC. CIN: 81-4137881 , United States, Active | Oct 12, 2016 | - | 21 (As on Dec 31, 2021) | - |
Sign up to download Spatial Genomics' company profile
Spatial Genomics's funding and investors
Spatial Genomics has raised a total funding of $56M over 8 rounds. Its first funding round was on Jul 01, 2018. Its latest funding round was a Grant (prize money) round on Jun 03, 2025 for $*****. 1 investor participated in its latest round. Spatial Genomics has 2 institutional investors.
Here is the list of recent funding rounds of Spatial Genomics:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jun 03, 2025 | 4548485 | Grant (prize money) | 4778703 | 2687731 | 6345045 | 8884181 |
May 30, 2025 | 8772670 | Grant (prize money) | 2258767 | 1482425 | 9843186 | |
Sep 21, 2023 | 7348894 | Grant (prize money) | 1584884 | 8532148 | 3111529 |
View details of Spatial Genomics's funding rounds and investors
Spatial Genomics' founders and board of directors
Founder? Claim ProfileThe founders of Spatial Genomics is Drew Kennedy.
Here are the details of Spatial Genomics' key team members:
- Drew Kennedy: Co-Founder of Spatial Genomics. Contact Info: 1 email address
- Kirsten Frieda: CEO of Spatial Genomics. Contact Info: 1 email address
View details of Spatial Genomics's Founder profiles and Board Members
Spatial Genomics' employee count trend
Spatial Genomics has 12 employees as of Aug 26. Here is Spatial Genomics's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Spatial Genomics's Competitors and alternates
Top competitors of Spatial Genomics include Cellectricon, Intana Bioscience and BioAssay Systems. Here is the list of Top 10 competitors of Spatial Genomics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Spatial Genomics 2018, Pasadena (United States), Series A | Developer of multiplexed assays for drug development | $56M | 44/100 | |
2nd | Cellectricon 2001, Molnbo (Sweden), Series C | Assay development for drug discovery services | $27.2M | 43/100 | |
3rd | Intana Bioscience 2008, Munich (Germany), Seed | Provider of services in assay development and screening on FCCS | $908K | 32/100 | |
4th | BioAssay Systems 2003, San Francisco (United States), Acquired | Innovating assay solutions for drug discovery and life science research | - | - | 32/100 |
5th | CellAura 2006, Nottingham (United Kingdom), Deadpooled | Fluorescent screening products for specific cellular targets | $7.6M | 29/100 | |
6th | Targeting Systems 1996, El Cajon (United States), Unfunded | Provider of services & products in stem cells, primary cells, and drug discovery | - | - | 24/100 |
7th | Synoptics Health 1985, Cambridge (United Kingdom), Unfunded | Fluorescence protein detection test | - | - | 24/100 |
8th | KXTbio 2011, Chapel Hill (United States), Seed | Provider of an assay platform and research tool for drug discovery | - | 24/100 | |
9th | MBMR Biolabs 2009, New York City (United States), Deadpooled | Fluorescent imaging tools based on bio-orthogonal chemistry | - | 15/100 | |
10th | Sonas Biopharma 2014, Eugene (United States), Deadpooled | Develops live-cell drug discovery platforms | - | - | 15/100 |
Looking for more details on Spatial Genomics's competitors? Click here to see the top ones
Spatial Genomics's Investments and acquisitions
Spatial Genomics has made no investments or acquisitions yet.
Reports related to Spatial Genomics
Here is the latest report on Spatial Genomics's sector:
News related to Spatial Genomics
•
Spatial Genomics Lays Off Two VPs, Other Employees Following $56M FundraisingGenomeWeb•Mar 04, 2022•Spatial Genomics
•
Fulgent Genetics Announces Strategic Investment in Spatial GenomicsBusiness Wire•Feb 24, 2022•Fulgent Genetics, Spatial Genomics
Are you a Founder ?
FAQs about Spatial Genomics
Explore our recently published companies
- Girls Media - Unfunded company
- This Waay - Sacramento based, 2021 founded, Unfunded company
- InsureSuite.com - 2000 founded, Unfunded company
- Language Technology - 1999 founded, Unfunded company
- FlightOne - Unfunded company
- Madame KI - Unfunded company